So, Arm Holdings (ARM) had a bit of a rough Tuesday. Its shares took a dip after Morgan Stanley decided to strike a more cautious note on the company's big AI-driven transition. Think of it like this: the firm is still bullish on the long game, but it's dialing back the near-term hype a notch. They downgraded the stock to Equal-Weight from Overweight, which is basically saying, "Hey, the risk and reward look pretty balanced here now." Oh, and they bumped up their price target to $150 from $135—so it's not all doom and gloom, just a reality check.

Analyst Take

Morgan Stanley analyst Lee Simpson laid it out pretty clearly. Arm's move into actually making chips, not just licensing the designs, lines up nicely with the rise of what he calls "agentic AI"—you know, those increasingly autonomous systems. But here's the catch: it introduces some real execution risks in the short term. Simpson pointed to strong early progress, like snagging talent and getting initial products out the door. But he warned that slow commercial scaling and rising costs could put a lid on the upside. He also flagged DRAM supply constraints and potential conflicts with existing licensees as factors that might cap the valuation at that $150 mark.

Simpson described this shift into silicon as a structural one, tied to how AI workloads are evolving. CPUs, he noted, will stay central in coordinating all these smart systems. And Arm's CPU roadmap, focused on artificial general intelligence (AGI), supports its long-term relevance and deeper integration into the ecosystem. So, the vision is solid—it's just the getting there that might be bumpy.

Growth Headwinds And Margin Pressure

However, he cautioned that chip revenue isn't going to scale up overnight. Meanwhile, those elevated research and engineering expenses could squeeze margins in the interim. Demand softness and memory-related constraints might also weigh on growth through fiscal 2027. And here's a tricky bit: Arm's entry into chipmaking could create some friction with its licensing partners. More overlap might mean customer pushback, which is never fun.

Simpson said the stock's valuation now reflects a sum-of-the-parts framework—applying a 30x EBIT multiple to the IP business and 15x to the chip segment. He outlined key risks to upside, including DRAM shortages, the outcome of Qualcomm-related litigation, and shifts in what licensees decide to do. Basically, there are a few wild cards on the table.

Financial Outlook And Long-Term Projections

Looking ahead, Simpson said clearer visibility into licensing growth and successful product launches could help sentiment. He expects chip revenue to reach about $1.2 billion by fiscal 2028 with 40% gross margins, though profitability might lag at first. Over time, as scale improves, margins could exceed 30% by fiscal 2031.

He projects total revenue of $9.28 billion and EPS of $4.16 in fiscal 2028, rising to $31 billion in revenue and $16.30 in EPS by fiscal 2031. Those are some big numbers, but they come with a side of patience.

ARM Price Action: Arm Holdings shares were down 4.75% at $141.71 at the time of publication on Tuesday, according to market data.